Johnson & Johnson Osake

Johnson & Johnson EV/FCF

EV/FCF (Yrityksen arvo suhteessa vapaaseen kassavirtaan) yhtiöstä Johnson & Johnson (JNJ) 17.8.2026 päivämäärällä on 28,76. Edellisenä vuonna EV/FCF (Yrityksen arvo suhteessa vapaaseen kassavirtaan) oli 28,33 — muutos 1,52 % (korkeampi).

EV/FCF

28,76

YoY

1,52%

Viimeksi päivitetty:

EV/FCF (Yrityksen arvo suhteessa vapaaseen kassavirtaan) yhtiöstä Johnson & Johnson on 2026 28,76 . EV/FCF (Yrityksen arvo suhteessa vapaaseen kassavirtaan) yhtiöstä Johnson & Johnson oli 2025 28,33 . Se laskee 1,52% korkeampi edelliseen vuoteen verrattuna.
Access this data via the Eulerpool API

Johnson & Johnson Osakeanalyysi

Mitä Johnson & Johnson tekee? Johnson & Johnson is an American company that was founded in 1886 by the brothers Robert, James, and Edward Johnson. The company is headquartered in New Brunswick, New Jersey, USA and is now an internationally operating company with more than 130,000 employees worldwide. The history of Johnson & Johnson began with the production of medical bandages. In 1887, the first self-adhesive wound plaster was invented and patented. In the following years, the product range was significantly expanded and now includes a wide range of health products. This includes pharmaceuticals, medical devices, hygiene products, personal care products, and baby products. The business model of Johnson & Johnson is to improve the lives of people worldwide. The company places great importance on innovation, quality, and sustainability. With its long-standing experience and expertise in the healthcare industry, Johnson & Johnson is able to understand the needs of customers and offer products tailored to their specific needs. Johnson & Johnson is now active in three main business areas: Consumer Health, Medical Devices and Diagnostics, and Pharmaceuticals. Within these business areas, there are a variety of brands and products that are among the most well-known in the world. The Consumer Health division of Johnson & Johnson is focused on the production of health and personal care products for consumers. Some well-known brands in this area include Listerine, Johnson's Baby, Neutrogena, and Nicorette. The company offers a wide range of products, from cold and allergy medications to skincare products and toothpastes. Medical Devices and Diagnostics is another major business area of Johnson & Johnson. The company is a leading provider of medical devices and diagnostic products worldwide. Products in this area include surgical systems, implantable devices, diagnostic tests, and imaging devices. Well-known brands in this area include Ethicon, Depuy Synthes, and Cordis. Pharmaceuticals is the third major business area of Johnson & Johnson. The company develops and produces innovative pharmaceuticals for the treatment of diseases such as cancer, diabetes, heart disease, and neurological disorders. Some well-known brands in this area include Remicade, Invega, and Zytiga. Johnson & Johnson is also known for its commitment to sustainability and corporate social responsibility. The company is committed to having a positive impact on the environment and the communities in which it operates. For example, Johnson & Johnson aims to reduce its CO2 emissions by 60% by 2030. Overall, Johnson & Johnson is a leading healthcare company focused on providing innovative and high-quality products that improve the lives of people worldwide. With a wide range of brands and products in various business areas, the company is well positioned to continue to be successful in the future. Johnson & Johnson on yksi Eurpooliin suosituimmista yhtiöistä.

Usein kysytyt kysymykset Johnson & Johnson osakkeesta

Yhtiön Johnson & Johnson EV/FCF (Yrityksen arvo suhteessa vapaaseen kassavirtaan) on 28,76 vuonna 2026.

EV/FCF (Yrityksen arvo suhteessa vapaaseen kassavirtaan) yhtiöstä Johnson & Johnson muuttui arvosta 28,33 arvoon 28,76, mikä edustaa 1,52 % muutosta. Arvo on korkeampi kuin edellisenä vuonna.

Eurpoolissa voit löytää EV/FCF (Yrityksen arvo suhteessa vapaaseen kassavirtaan) Johnson & Johnson:n täydellisen historiallisen kehityksen vuodesta 2006 lähtien – vuotuisten arvojen, kaavioiden ja yksityiskohtaisen analyysin kanssa.

EV/FCF-suhde mittaa yrityksen arvoa suhteessa vapaaseen kassavirtaan. Se heijastaa yrityksen todellista kassantuottokykyä.

Arvioidakseen EV/FCF (Yrityksen arvo suhteessa vapaaseen kassavirtaan):n, on olennaista verrata sitä saman alan ja sektorin kilpailijoihin. Eulerpoolissa voit löytää suoria alan vertailuja EV/FCF (Yrityksen arvo suhteessa vapaaseen kassavirtaan):lle.

"Hyvä" vaihtelee alan ja yrityksen kehitysvaiheen mukaan. Eulerpoolissa voit verrata EV/FCF (Yrityksen arvo suhteessa vapaaseen kassavirtaan):n Johnson & Johnson alan vertaisiin ja alan keskiarvoon arvioidaksesi houkuttelevuuden.

Access this data via the Eulerpool API

Arvostus — Johnson & Johnson

Kaikki tunnusluvut — Johnson & Johnson